Inflammatory state and immunity are the two patient conditions that need to be addressed when infectious disease hits a population or when co-infection exists in chronic disease conditions. The Magellan Therapeutic Inc. platform addresses these two patient conditions. The method employs replenishing diminished levels of a key component of the lectin pathway by cell and gene therapy. The lectin pathway is responsible for immunity as well as inflammation. Every person on Earth has probably taken a small molecule or an injection of a steroid for inflammation or antibiotics to treat infection. The waste generated from the entire cycle from disposable plastics, gowns, masks, to biowaste from liquid biopsy, patient sputum, fecal and urine is a neglected aspect of disease burden. Moreover, the cost of generating potable water from contaminants ranging from drug excretion in sewage to disturbance in soil and water pH to drug resistant pathogen mutants is largely overlooked. A discussion on nipping these issues in the bud from bench to patient is presented. The dots are connected via simple diagrams for a snapshot of the bigger picture. Solutions to the crisis are provided for debate and implementation irrespective of political viewpoints. The goal post does not move. An alternative model in new trade free parks is proposed with sustained nondilutive funding. The goal is human flourishing.